Tailor Medical Cannabis Treatment: Consider Prior Cannabis Exposure (for Doctors)

To access this resource, please complete your purchase. Once purchased, the resource will be available in your learning portal.

The topics explored within each module of this course are outlined below.

Module 1: Introduction

In this module, you’ll receive an overview of the course, including information about subsequent modules.

Module 2: Cannabis compounds

• The types of compounds present in cannabis – their features and how they may affect the body
• The therapeutic and psychoactive properties of THC
• The therapeutic properties of CBD
• How the cannabis compounds can work together to produce better therapeutic outcomes via the entourage effect
• Different cannabis strains and how they may be suited for individual treatment needs

Module 3: The Endocannabinoid System and Endocannabinoid Tone

• How the ECS was first discovered
• The role of the ECS in maintaining homeostasis for positive health outcomes
• Typical functioning of the ECS, including the critical role of cannabinoids and cannabinoid receptors
• Endocannabinoid tone
• How exposure to exogenous cannabinoids may affect endocannabinoid tone and ECS function
• Treatment considerations for patients with high and low exposure to cannabis

Module 4: Exposure Dimensions - Tolerance & Experience

• Factors to consider for patient-centric treatment
  Benefits of accounting for prior cannabis exposure
• The 2 dimensions of cannabis exposure – tolerance and experience
• Key categorisations and indicators of cannabis tolerance levels, and their high-level implications on treatment
• How patients' experience with cannabis may, or may not, relate to their medical cannabis knowledge and education
• Approaches and principles to provide effective education to patients
• Key areas of education for patients – including general information and common misconceptions
• Key barriers to accurate assessment of patient exposure, their identifiers and solutions

Module 5: Set Treatment Goals

• Examples of treatment goals for low- and high-exposure patients
• Considerations and recommendations for devising treatment goals that account for patient prior exposure

Module 6: Select Suitable Products

• Benefits of medical cannabis over black market cannabis
• Types of medical cannabis product "categories"
• Available product and administration options
• Considerations and recommendations for product selection based on patients’ prior exposure levels

Module 7: Dosage, Titration and Follow-Up

• General guidelines to dosage and titration for medical cannabis 
• The formula to determine THC content of a dosage
• How to vary dosage amounts for patients with different exposure levels
• Considerations and recommendations for dosage and titration based on patients' prior exposure levels
• Follow-up and monitoring based on patients' prior exposure levels

This activity has been endorsed by Australian College of Rural and Remote Medicine (ACRRM) and The Royal Australian College of General Practitioners (RACGP).

ACRRM APPROVED ACTIVITY

Completion of this educational activity entitles eligible participants to claim 6 CPD hours with ACRRM.

RACGP APPROVED ACTIVITY

This activity has been approved with RACGP for the following hours and types:

• Educational activities hours: 3
• Reviewing performance hours: 2.5
• Measuring outcome hours: 0